Literature DB >> 3411628

Detection of antigens associated with Epstein-Barr virus replication in extracts from biopsy specimens of nasopharyngeal carcinomas.

J Luka1, Z E Deeb, D P Hartmann, B Jenson, G R Pearson.   

Abstract

By using monoclonal antibodies to different Epstein-Barr virus (EBV) polypeptides in combination with immunoblotting, we detected antigens associated with EBV replication in extracts from nasopharyngeal carcinoma (NPC) biopsy specimens. Major polypeptides associated with both the diffuse and the restricted components of the early antigen (EA) complex were found in extracts from nine of nine NPC biopsy specimens. Cells from an additional NPC biopsy specimen, passaged repeatedly in nude mice, were found to be positive for the major EA (restricted) polypeptide. This approach revealed that extracts from three of 14 biopsy specimens form other benign and malignant diseases also expressed these viral polypeptides. Therefore, for the first time, these results conclusively demonstrate the presence of EA polypeptides in extracts from NPC biopsy specimens. This finding provides at least a partial explanation for the reported prognostic value of antibodies to this antigen in patients with this disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3411628     DOI: 10.1093/jnci/80.14.1164

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  9 in total

1.  Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas.

Authors:  G Niedobitek; L S Young; C K Sam; L Brooks; U Prasad; A B Rickinson
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

2.  Linear epitopes of the replication-activator protein of Epstein-Barr virus recognised by specific serum IgG in nasopharyngeal carcinoma.

Authors:  H M Cheng; Y T Foong; A J AbuSamah; J Dillner; C K Sam; U Prasad
Journal:  Cancer Immunol Immunother       Date:  1995-04       Impact factor: 6.968

3.  Effect of Epstein-Barr virus infection on global gene expression in nasopharyngeal carcinoma.

Authors:  Yuan-Chii Gladys Lee; Yu-Chyi Hwang; Kuang-Chi Chen; Yong-Shiang Lin; Dah-Yeou Huang; Tao-Wei Huang; Cheng-Yan Kao; Han-Chung Wu; Chin-Tarng Lin; Chi-Ying F Huang
Journal:  Funct Integr Genomics       Date:  2006-09-19       Impact factor: 3.410

4.  Malignant transformation of Epstein-Barr virus-negative Akata cells by introduction of the BARF1 gene carried by Epstein-Barr virus.

Authors:  Wang Sheng; Gisèle Decaussin; Audrey Ligout; Kenzo Takada; Tadamasa Ooka
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

5.  Presence of the diffuse early antigen of Epstein-Barr virus in lymphomas and lymphoproliferative disorders.

Authors:  B Z Katz; U Saini
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

6.  BAMHI DNA fragment H-polymorphism of Epstein-Barr virus is associated with the mutations present in an 89 BP sequence localized in EBNA2 gene.

Authors:  Wang Sheng; Abdelmadjide Bouguermouh; Maklouf Bouzid; Djamel Djennaoui; Tadamasa Ooka
Journal:  Virus Genes       Date:  2004-08       Impact factor: 2.332

7.  Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.

Authors:  Shih-Hsin Chiu; Chung-Chun Wu; Chih-Yeu Fang; Shu-Ling Yu; Hui-Yu Hsu; Yen-Hung Chow; Jen-Yang Chen
Journal:  Oncotarget       Date:  2014-09-30

8.  Arsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cells.

Authors:  Qinyan Yin; Mark Sides; Christopher H Parsons; Erik K Flemington; Joseph A Lasky
Journal:  Virol J       Date:  2017-06-21       Impact factor: 4.099

9.  Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin.

Authors:  Chung-Chun Wu; Chih-Yeu Fang; Yu-Jhen Cheng; Hui-Yu Hsu; Sheng-Ping Chou; Sheng-Yen Huang; Ching-Hwa Tsai; Jen-Yang Chen
Journal:  J Biomed Sci       Date:  2017-01-05       Impact factor: 8.410

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.